ImpriMed
A precision-oncology service that tests live cancer cells against drugs and uses clinical data to predict which treatments may work best for each patient.
$10MSeries A2 bridge
ParticipantND
NAVER D2SF
Activity from announced rounds
Activity in this selectionahren-innovation-capital-1ef04271
- Rounds participated in
- 10
- Confirmed lead rounds
- 0 9 roles undisclosed
- New companies
- 10 First participation on record · 0 follow-on
- Funding in participating rounds
- $25.6M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
1 more
Media & gaming1
By country
Rounds
10 in this selectionF4GE
Standardizes Korean factory data to connect manufacturers with global defense and industrial buyers
UndisclosedSeed
Role not disclosedNdotLight
Generates simulation-ready 3D data for physical AI training
₩15BSeries B
Role not disclosedSAZO
Cross-border shopping infrastructure connecting commerce platforms with payments, logistics and customs processes.
UndisclosedStrategic
Role not disclosedSoundable Health
Develops AI-powered acoustic analysis for clinical-grade diagnostics through everyday devices
UndisclosedUndisclosed
Role not disclosedNuvilab
Develops AI-powered nutrition analytics solution for healthcare
UndisclosedUndisclosed
Role not disclosedAnyware Robotics
Develops robots for autonomous material handling operations in logistics
UndisclosedSeed
Role not disclosedKhameleon
Develops robots for housekeeping tasks in hotels
UndisclosedPre-Seed
Role not disclosedCNAPS.AI
Develops AI workflow automation platform connecting multiple AI models
UndisclosedSeed
Role not disclosedCashmere
Connects premium content publishers with AI companies, providing data infrastructure for licensin...
$5MSeed
Role not disclosed